AzTrials
AzTrials

Neuromuscular BlockadeNCT02239965

Qualitative Analysis of Barriers to Consistent Use of Neuromuscular Monitoring in General Anaesthesia

An observational study of Neuromuscular Blockade, run by Herlev Hospital at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Monitoring the degree of neuromuscular blockade in general anaesthesia reduces complications and patient discomfort. However, monitoring is not applied consistently by Danish anaesthesia personnel. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Neuromuscular Blockade
How many people
40 participants
Where
1 siteDenmark
Study dates
Jun 2014to Mar 2015
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Anaesthesiologists and nurse anaesthetists at Danish anaesthesia departments.

Who may be able to join

  • has been working in the field of anaesthesiology for at least 1 year.

Who cannot join

  • none

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Herlev Hospital

    Herlev

Other trials in Denmark

About this study

Monitoring the degree of neuromuscular blockade in general anaesthesia reduces complications and patient discomfort. However, monitoring is not applied consistently by Danish anaesthesia personnel. Surveys show that part of the explanation is that the anaesthetists often experience problems with the equipment used for monitoring, though the problems have not been described in detail.

We hypothesise that the lack of consistent monitoring in general anaesthesia is caused by insecurity in the anaesthesia personnel's set-up and use of the equipment, as well as in interpreting the measurement results.

Keywords
Neuromuscular blockade, Neuromuscular monitoring, Focus group interview, Clinical observation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT02239965
Study groupRoleWhat they receive
Anaesthesia personnelAnaesthesiologists and nurse anaesthetists

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Description of the barriers to consistent neuromuscular monitoring, based on a qualitative analysis of focus group interviews with anaesthesiologists and nurse anaesthetists

    Focus group interviews will collect participants' perspectives and will be analyzed for thoughts, opinions, and feelings in regard to neuromuscular monitoring. Specific problems experienced with the equipment and other possible barriers to the consistent use of monitoring will be described qualitatively.

    Measured: Focus group interviews conducted Sep. - Oct. 2014 (2 months)

Secondary outcomes (1)
  1. Description of the problems experienced with neuromuscular monitoring in daily clinical practice

    The problems experienced with neuromuscular monitoring will be described through a qualitative analysis of clinical observations of the personnel's daily use of the monitoring equipment,

    Measured: Clinical observations conducted in Sep. - Oct. 2014 (2 months)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Sep 2014 (estimated)
  2. Study startJun 2014
  3. Primary completionMar 2015
  4. Study completionMar 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02239965
Sponsor's protocol ID
JLT-NM3
Status last verified
Oct 2019
First submitted
9 Sep 2014
Last updated
1 Nov 2019
Results posted
No

Questions about this trial

What is this clinical trial studying?

An observational study of Neuromuscular Blockade, run by Herlev Hospital at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Nov 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Description of the barriers to consistent neuromuscular monitoring, based on a qualitative analysis of focus group interviews with anaesthesiologists and nurse anaesthetists (time frame: Focus group interviews conducted Sep. - Oct. 2014 (2 months)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Nov 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in